Rein Therapeutics, Inc. (RNTX) › Total LiabilitiesRein Therapeutics, Inc. (RNTX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $4.08M2017: $4.89M2018: $10.71M2019: $10.43M2020: $4.18M2021: $4.58M2022: $3.38M2023: $7.71M2024: $7.80M2025: $7.24M$7.24M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$7.24M-7.2%2024$7.80M+1.1%2023$7.71M+127.9%2022$3.38M-26.1%2021$4.58M+9.5%2020$4.18M-59.9%2019$10.43M-2.7%2018$10.71M+119.0%2017$4.89M+19.8%2016$4.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share